Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-17

Clinical Trial Update: Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of sarecycline for acne vulgaris has completed, with results posted in May 2018. The study was sponsored by Alm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sarecycline (sarecycline)

Snippet

Sponsor: Almirall, S.A. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2018-05-17